BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kamble PG, Hetty S, Vranic M, Almby K, Castillejo-López C, Abalo XM, Pereira MJ, Eriksson JW. Proof-of-concept for CRISPR/Cas9 gene editing in human preadipocytes: Deletion of FKBP5 and PPARG and effects on adipocyte differentiation and metabolism. Sci Rep 2020;10:10565. [PMID: 32601291 DOI: 10.1038/s41598-020-67293-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Romanelli SM, Lewis KT, Nishii A, Rupp AC, Li Z, Mori H, Schill RL, Learman BS, Rhodes CJ, MacDougald OA. BAd-CRISPR: inducible gene knockout in interscapular brown adipose tissue of adult mice. J Biol Chem 2021;:101402. [PMID: 34774798 DOI: 10.1016/j.jbc.2021.101402] [Reference Citation Analysis]
2 Grancieri M, Martino HSD, Gonzalez de Mejia E. Protein Digests and Pure Peptides from Chia Seed Prevented Adipogenesis and Inflammation by Inhibiting PPARγ and NF-κB Pathways in 3T3L-1 Adipocytes. Nutrients 2021;13:E176. [PMID: 33430086 DOI: 10.3390/nu13010176] [Reference Citation Analysis]
3 Bauder M, Meyners C, Purder PL, Merz S, Sugiarto WO, Voll AM, Heymann T, Hausch F. Structure-Based Design of High-Affinity Macrocyclic FKBP51 Inhibitors. J Med Chem 2021;64:3320-49. [PMID: 33666419 DOI: 10.1021/acs.jmedchem.0c02195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Tsagkaraki E, Nicoloro SM, DeSouza T, Solivan-Rivera J, Desai A, Lifshitz LM, Shen Y, Kelly M, Guilherme A, Henriques F, Amrani N, Ibraheim R, Rodriguez TC, Luk K, Maitland S, Friedline RH, Tauer L, Hu X, Kim JK, Wolfe SA, Sontheimer EJ, Corvera S, Czech MP. CRISPR-enhanced human adipocyte browning as cell therapy for metabolic disease. Nat Commun 2021;12:6931. [PMID: 34836963 DOI: 10.1038/s41467-021-27190-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sarsenbayeva A, Pereira MJ, Nandi Jui B, Ahmed F, Dipta P, Fanni G, Almby K, Kristófi R, Hetty S, Eriksson JW. Excess glucocorticoid exposure contributes to adipose tissue fibrosis which involves macrophage interaction with adipose precursor cells. Biochem Pharmacol 2022;:114976. [PMID: 35202577 DOI: 10.1016/j.bcp.2022.114976] [Reference Citation Analysis]
6 Dufau J, Shen JX, Couchet M, De Castro Barbosa T, Mejhert N, Massier L, Griseti E, Mouisel E, Amri EZ, Lauschke VM, Rydén M, Langin D. In vitro and ex vivo models of adipocytes. Am J Physiol Cell Physiol 2021;320:C822-41. [PMID: 33439778 DOI: 10.1152/ajpcell.00519.2020] [Reference Citation Analysis]
7 Barge S, Deka B, Kashyap B, Bharadwaj S, Kandimalla R, Ghosh A, Dutta PP, Samanta SK, Manna P, Borah JC, Talukdar NC. Astragalin mediates the pharmacological effects of Lysimachia candida Lindl on adipogenesis via downregulating PPARG and FKBP51 signaling cascade. Phytother Res 2021. [PMID: 34734439 DOI: 10.1002/ptr.7320] [Reference Citation Analysis]
8 Romanelli SM, MacDougald OA. Viral and Nonviral Transfer of Genetic Materials to Adipose Tissues: Toward a Gold Standard Approach. Diabetes 2020;69:2581-8. [PMID: 33219099 DOI: 10.2337/dbi20-0036] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Pereira MJ, Vranic M, Kamble PG, Jernow H, Kristófi R, Holbikova E, Skrtic S, Kullberg J, Svensson MK, Hetty S, Eriksson JW. CDKN2C expression in adipose tissue is reduced in type II diabetes and central obesity: impact on adipocyte differentiation and lipid storage? Transl Res 2021:S1931-5244(21)00286-3. [PMID: 34896253 DOI: 10.1016/j.trsl.2021.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Pereira MJ, Andersson‐assarsson JC, Jacobson P, Kamble P, Taube M, Sjöholm K, Carlsson LMS, Svensson P. Human adipose tissue gene expression of solute carrier family 19 member 3 ( SLC19A3 ); relation to obesity and weight‐loss. Obesity Science & Practice 2022;8:21-31. [DOI: 10.1002/osp4.541] [Reference Citation Analysis]